Delivery Order SPE2DB20D3505-SPE2DB25FYCND
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,186.03 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30 count) on October 27, 2025, with completion expected by October 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents pharmaceutical procurement to support federal medical supply needs. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $53,675.87 to AmerisourceBergen Drug Corp for RINVOQ ER 30 MG tablets (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $41,153.31 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the opportunity was open to all...
- The Defense Logistics Agency awarded a delivery order valued at $32,252.58 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 5, 2025, with completion targeted for November 6, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a Delivery Order valued at $24,066.84 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $26,581.58 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 1, 2025, with an ultimate completion date of July 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $40,986.91 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $45,395.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency (DLA) awarded a $35,941.65 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-tablet units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a delivery order valued at $15,339.52 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...